Current Value of Holding

$0

Shares

0

% of Portfolio

0.00%

Average Buy Price

$20.7

Avg closing price
Price range

13 Stanley Druckenmiller Nektar Therapeutics Trades

The first Nektar Therapeutics trade was made in Q4 2014. Since then Stanley Druckenmiller bought shares six more times and sold shares on six occasions. The investor sold all their shares in Q4 2021 and doesn't own any shares in Nektar Therapeutics anymore.

Avg closing price
Price range
Sold -1 Million shares Q4 2021
Avg closing price $14.46
Price range $10.83 - $18.41
New holding (+1 Million shares) Q1 2021
Avg closing price $20.75
Price range $16.56 - $25.46
Sold -311 Thousand shares Q1 2020
Avg closing price $20.62
Price range $14.47 - $27.96
New holding (+311 Thousand shares) Q4 2019
Avg closing price $19.33
Price range $15.87 - $23.12
Sold -1.19 Million shares Q2 2018
Avg closing price $76.87
Price range $46.25 - $104.45
Sold 35.0% shares (-642 Thousand shares) Q1 2018
Avg closing price $85.89
Price range $57.40 - $108.44
Increased shares by 57.3% (+668 Thousand shares) Q4 2017
Avg closing price $39.43
Price range $23.02 - $60.50
Increased shares by 75.2% (+501 Thousand shares) Q2 2017
Avg closing price $19.27
Price range $17.54 - $22.57
New holding (+666 Thousand shares) Q1 2017
Avg closing price $14.99
Price range $11.75 - $24.20
Sold -572 Thousand shares Q4 2016
Avg closing price $13.55
Price range $11.85 - $17.48
New holding (+572 Thousand shares) Q3 2016
Avg closing price $17.17
Price range $14.09 - $19.68
Sold -655 Thousand shares Q2 2015
Avg closing price $11.47
Price range $9.52 - $13.84
New holding (+655 Thousand shares) Q4 2014
Avg closing price $14.30
Price range $12.07 - $17.05

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!